MASSA, FEDERICO

MASSA, FEDERICO  

100009 - Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili  

Mostra records
Risultati 1 - 20 di 78 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG-PET/CT (FDG-PET) in Neurodegenerative Disease 1-gen-2019 Capitanio, Selene; Bauckneht, Matteo; Arnaldi, Dario; Massa, Federico; Meli, Riccardo; Ceriani, Valentina; Nobili, Flavio; Morbelli, Silvia
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 1-gen-2022 Ruscitti, Federica; Origone, Paola; Rosti, Giulia; Trevisan, Lucia; Marchese, Roberta; Brugnolo, Andrea; Massa, Federico; Castellini, Paola; Mandich, Paola
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection 1-gen-2021 Grisanti, S. G.; Franciotta, D.; Garnero, M.; Zuppa, A.; Massa, F.; Mobilia, E. M.; Pesce, G.; Schenone, A.; Benedetti, L.
Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature 1-gen-2021 Demichelis, C.; Grisanti, S.; Massa, F.; Serrati, C.; Beronio, A.; Mannironi, A.; Mobilia, E.; Briani, C.; Schenone, A.; Benedetti, L.
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 1-gen-2019 De Carli, Fabrizio; Nobili, Flavio; Pagani, Marco; Bauckneht, Matteo; Massa, Federico; Grazzini, Matteo; Jonsson, Cathrine; Peira, Enrico; Morbelli, Silvia; Arnaldi, Dario.
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 1-gen-2022 Massa, F.; Chincarini, A.; Bauckneht, M.; Raffa, S.; Peira, E.; Arnaldi, D.; Pardini, M.; Pagani, M.; Orso, B.; Donegani, M. I.; Brugnolo, A.; Biassoni, E.; Mattioli, P.; Girtler, N.; Guerra, U. P.; Morbelli, S.; Nobili, F.
Alzheimer's disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era 1-gen-2024 Sofia, Luca; Massa, Federico; Pardini, Matteo; Arnaldi, Dario; Bauckneht, Matteo; Morbelli, Silvia
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 1-gen-2020 Orso, B.; Arnaldi, D.; Fama, F.; Girtler, N.; Brugnolo, A.; Doglione, E.; Filippi, L.; Massa, F.; Peira, E.; Bauckneht, M.; Morbelli, S.; Nobili, F.; Pardini, M.
Autoimmune encephalitis: what the radiologist needs to know 1-gen-2024 Sanvito, F.; Pichiecchio, A.; Paoletti, M.; Rebella, G.; Resaz, M.; Benedetti, L.; Massa, F.; Morbelli, S.; Caverzasi, E.; Asteggiano, C.; Businaro, P.; Masciocchi, S.; Castellan, L.; Franciotta, D.; Gastaldi, M.; Roccatagliata, L.
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 1-gen-2020 Massa, F; Zuppa, A; Pesce, G; Demichelis, C; Bergamaschi, M; Garnero, M; Briani, C; Ferrari, S; Schenone, A; Benedetti, L
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 1-gen-2021 Donegani, M. I.; Miceli, A.; Pardini, M.; Bauckneht, M.; Chiola, S.; Pennone, M.; Marini, C.; Massa, F.; Raffa, S.; Ferrarazzo, G.; Arnaldi, D.; Sambuceti, G.; Nobili, F.; Morbelli, S.
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 1-gen-2021 Brugnolo, Andrea; Girtler, Nicola; Doglione, Elisa; Orso, Beatrice; Massa, Federico; Donegani, Maria Isabella; Bauckneht, Matteo; Morbelli, Silvia; Arnaldi, Dario; Nobili, Flavio; Pardini, Matteo
Case 4: Parkinson’s Disease with Onset as Mild Cognitive Impairment (MCI) 1-gen-2021 Massa, F.; Morbelli, S.
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 1-gen-2022 Bellucci, Margherita; Germano, Francesco; Grisanti, Stefano; Castellano, Chiara; Tazza, Francesco; Mobilia, Emanuela Maria; Visigalli, Davide; Novi, Giovanni; Massa, Federico; Rossi, Silvia; Durando, Paolo; Cabona, Corrado; Schenone, Angelo; Franciotta, Diego; Benedetti, Luana
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 1-gen-2023 Massa, F.; Martinuzzo, C.; Gomez de San Jose, N.; Pelagotti, V.; Kreshpa, W.; Abu-Rumeileh, S.; Barba, L.; Mattioli, P.; Orso, B.; Brugnolo, A.; Girtler, N.; Vigo, T.; Arnaldi, D.; Serrati, C.; Uccelli, A.; Morbelli, S.; Chincarini, A.; Otto, M.; Pardini, M.
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 1-gen-2022 Barba, L.; Abu Rumeileh, S.; Bellomo, G.; Paolini Paoletti, F.; Halbgebauer, S.; Oeckl, P.; Steinacker, P.; Massa, F.; Gaetani, L.; Parnetti, L.; Otto, M.
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 1-gen-2024 Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Rudolf Thal, Dietmar; Parnetti, Lucilla; Otto, Markus
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 1-gen-2020 Orso, B; Mattei, C; Arnaldi, D; Massa, F; Serafini, G; Plantone, D; Doglione, E; Grafman, J; Nobili, F; Pardini, M.
Clinical utility and research frontiers of neuroimaging in movement disorders 1-gen-2017 Nobili, FLAVIO MARIANO; Westman, Eric; Kogan, Rosalie V; Pereira, Joana B; Massa, Federico; Grazzini, Matteo; Meles, Sanne K; Leenders, Klaus L.
Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply 1-gen-2024 Massa, F.; Villain, N.; Cotta Ramusino, M.; Frisoni, G. B.